AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34151819 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular stabilization exercises using elastic bands at 10 repetitions/set, 3 sets/day, 3 days/week for 4 weeks
Number of subjects: 39
Study 34151819 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercises)
Number of subjects: 39
Study 32215728 — intervention group
Group type: EXPERIMENTAL
Intervention: Local, semi-automatic reconstruction
Number of subjects: 20
Study 35972211 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 0
Study 35972211 — intervention group
Group type: COMPARATOR
Intervention: OCS (Oral Corticosteroids)
Number of subjects: 0
Study 34332788 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/Ω-3 fatty acids 4 g (UI-018)
Number of subjects: 200
Study 34332788 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 40 mg + placebo (control)
Number of subjects: 200
Study 33196567 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential procedure (scleral-fixated IOL implantation followed by DSAEK)
Number of subjects: 40
Study 33196567 — intervention group
Group type: COMPARATOR
Intervention: Simultaneous procedure (DSAEK with SF IOL)
Number of subjects: 40
Study 33035186 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body neutral douche
Number of subjects: 68
Study 34491207 — intervention group
Group type: EXPERIMENTAL
Intervention: Multistrategy behavioral intervention with choice architecture strategies embedded in the web-based system (n=9 schools)
Number of subjects: 2207
Study 34491207 — intervention group
Group type: EXPERIMENTAL
Intervention: Multistrategy behavioral intervention
Number of subjects: 2207
Study 34491207 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard web-based ordering system only, n=8 schools)
Number of subjects: 2207
Study 35728603 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar electrocautery device for complete salpingectomy
Number of subjects: 39
Study 35522325 — intervention group
Group type: EXPERIMENTAL
Intervention: No mask
Number of subjects: 31
Study 35522325 — intervention group
Group type: COMPARATOR
Intervention: Surgical mask
Number of subjects: 31
Study 35522325 — intervention group
Group type: COMPARATOR
Intervention: FFP-2 mask
Number of subjects: 31
Study 33904781 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation monologue
Number of subjects: 30
Study 33904781 — intervention group
Group type: COMPARATOR
Intervention: Nature sounds
Number of subjects: 30
Study 32861614 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional intervention focusing on neuroleptics and potentially inadequate medications
Number of subjects: 862
Study 34755262 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (127 patients)
Number of subjects: 140
Study 34755262 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy (13 patients)
Number of subjects: 140
Study 34755262 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 140
Study 34755262 — intervention group
Group type: EXPERIMENTAL
Intervention: Incomplete staging surgery
Number of subjects: 140
Study 32068426 — intervention group
Group type: EXPERIMENTAL
Intervention: MATCH (modular, transdiagnostic, behavioral/cognitive‐behavioral intervention)
Number of subjects: 174
Study 32068426 — intervention group
Group type: EXPERIMENTAL
Intervention: MATCH
Number of subjects: 174
Study 32068426 — intervention group
Group type: COMPARATOR
Intervention: MATCH and SMT
Number of subjects: 174
Study 32068426 — intervention group
Group type: COMPARATOR
Intervention: SMT (standard manualized treatments)
Number of subjects: 174
Study 32068426 — intervention group
Group type: COMPARATOR
Intervention: UC (usual care)
Number of subjects: 174
Study 35747946 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (high-intensity interval training)
Number of subjects: 0
Study 35747946 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT (moderate-intensity continuous training)
Number of subjects: 0
Study 35747946 — intervention group
Group type: COMPARATOR
Intervention: CG (control group)
Number of subjects: 0
Study 34238553 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 3113
Study 34238553 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 3113
Study 32461298 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive radiotherapy using a library of three plans (small, medium and large)
Number of subjects: 62
Study 32461298 — intervention group
Group type: COMPARATOR
Intervention: Single-standard plan
Number of subjects: 62
Study 32461298 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive radiotherapy
Number of subjects: 62
Study 34235822 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital educational app
Number of subjects: 61
Study 34235822 — intervention group
Group type: EXPERIMENTAL
Intervention: Concrete materials
Number of subjects: 61
Study 34235822 — intervention group
Group type: COMPARATOR
Intervention: Business-as-usual control group
Number of subjects: 61
Study 33781339 — intervention group
Group type: EXPERIMENTAL
Intervention: Creating a peritoneal flap
Number of subjects: 300
Study 33781339 — intervention group
Group type: COMPARATOR
Intervention: Standard procedure without creation of a flap (control)
Number of subjects: 300
Study 32759236 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune checkpoint inhibitors (ICIs)
Number of subjects: 55
Study 98167534 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural network model
Number of subjects: 1674
Study 98167534 — intervention group
Group type: COMPARATOR
Intervention: Logistic regression
Number of subjects: 1674
Study 36739325 — intervention group
Group type: COMPARATOR
Intervention: 40Hz-tACS_PRE
Number of subjects: 75
Study 36739325 — intervention group
Group type: COMPARATOR
Intervention: 40Hz-tACS_ON
Number of subjects: 75
Study 36739325 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham
Number of subjects: 75
Study 33606009 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg twice daily for 7 days)
Number of subjects: 177
Study 33606009 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin (single 1-g dose)
Number of subjects: 177
Study 33457425 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (≤1000 mg/d) added to insulin for 24 weeks
Number of subjects: 17
Study 33457425 — intervention group
Group type: COMPARATOR
Intervention: Insulin monotherapy
Number of subjects: 17
Study 33946128 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization in the evening (21.00 to 23.00) by trained nurses and physiotherapists
Number of subjects: 46
Study 33946128 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 46
Study 32594858 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) sessions with 5 sets of 8-10RM on squat and leg press exercises, recovery intervals of 24h, 48h, or 72h
Number of subjects: 14
Study 32594858 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) sessions with 5 sets of 8-10RM on squat and leg press exercises, recovery intervals of 48h
Number of subjects: 14
Study 32594858 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) sessions with 5 sets of 8-10RM on squat and leg press exercises, recovery intervals of 72h
Number of subjects: 14
Study 34587568 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT) intervention
Number of subjects: 24
Study 34587568 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 33402601 — intervention group
Group type: EXPERIMENTAL
Intervention: Drip intravenous administration of endostar (DE)
Number of subjects: 98
Study 33402601 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous administration of endostar (CE)
Number of subjects: 98
Study 32905642 — intervention group
Group type: EXPERIMENTAL
Intervention: Haploidentical stem cell transplantation (Haplo‐HSCT)
Number of subjects: 110
Study 32905642 — intervention group
Group type: COMPARATOR
Intervention: Matched unrelated donor transplantation (MUD‐HSCT)
Number of subjects: 110
Study 32398580 — intervention group
Group type: EXPERIMENTAL
Intervention: Transverse approach
Number of subjects: 60
Study 32398580 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasagittal approach
Number of subjects: 60
Study 34953810 — intervention group
Group type: EXPERIMENTAL
Intervention: Male-specific invitation
Number of subjects: 75810
Study 34953810 — intervention group
Group type: EXPERIMENTAL
Intervention: Unisex invitation
Number of subjects: 75810
Study 34953810 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard invitation
Number of subjects: 75810
Study 34953810 — intervention group
Group type: COMPARATOR
Intervention: No invitation (control)
Number of subjects: 75810
Study 34551809 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Lifestyle Program (HeLP)
Number of subjects: 346
Study 34551809 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 346
Study 34224918 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild intermittent hypoxia (MIH) exposure (15 % O2, 3 × 2 h/day for 7 days)
Number of subjects: 12
Study 34224918 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild intermittent hypoxia (MIH) exposure
Number of subjects: 12
Study 34224918 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (21 % O2)
Number of subjects: 12
Study 32172039 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived 8-h sleep opportunity (actual 5-h sleep)
Number of subjects: 16
Study 32172039 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived 5-h sleep opportunity (actual 8-h sleep)
Number of subjects: 16
Study 32172039 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-h sleep opportunity with perceived 5-h sleep
Number of subjects: 16
Study 32172039 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-h sleep opportunity with perceived 8-h sleep
Number of subjects: 16
Study 32172039 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived 8-h sleep opportunity (regardless of actual duration)
Number of subjects: 16
Study 36200478 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration (Icon) with up to 3 etching procedures (Inf)
Number of subjects: 15
Study 36200478 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish (Tiefenfluorid) (FV)
Number of subjects: 15
Study 34619106 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 4304
Study 34619106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study 33020051 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals who developed diabetes
Number of subjects: 7163
Study 33020051 — intervention group
Group type: EXPERIMENTAL
Intervention: Women who developed diabetes
Number of subjects: 7163
Study 33020051 — intervention group
Group type: COMPARATOR
Intervention: Individuals who did not develop diabetes
Number of subjects: 7163
Study 33452179 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic dilation (PD) using a 35 mm balloon
Number of subjects: 42
Study 33452179 — intervention group
Group type: COMPARATOR
Intervention: Sham dilation
Number of subjects: 42
Study 33452179 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic dilation (PD)
Number of subjects: 42
Study 34994685 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal feedback
Number of subjects: 182
Study 34994685 — intervention group
Group type: EXPERIMENTAL
Intervention: Written feedback
Number of subjects: 182
Study 32438879 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood maltreatment in ultra-high risk individuals
Number of subjects: 202
Study 32438879 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical and emotional neglect
Number of subjects: 202
Study 32438879 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical abuse
Number of subjects: 202
Study 32438879 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical neglect
Number of subjects: 202
Study 32438879 — intervention group
Group type: COMPARATOR
Intervention: Control group (no childhood maltreatment)
Number of subjects: 202
Study 35526590 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprostene bunod (LBN) ophthalmic solution 0.024%
Number of subjects: 50
Study 35526590 — intervention group
Group type: COMPARATOR
Intervention: Timolol maleate 0.5%
Number of subjects: 50
Study 34347883 — intervention group
Group type: EXPERIMENTAL
Intervention: Crenezumab (600–7,200 mg)
Number of subjects: 140
Study 34347883 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4–40 mL)
Number of subjects: 140
Study 34347883 — intervention group
Group type: EXPERIMENTAL
Intervention: Crenezumab with rHuPH20
Number of subjects: 140
Study 34347883 — intervention group
Group type: EXPERIMENTAL
Intervention: Crenezumab (high-dose, high-concentration, high-volume)
Number of subjects: 140
Study 35978329 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 764524 (0.5, 1.0, or 2.5 mg) in the SRD part
Number of subjects: 30
Study 35978329 — intervention group
Group type: COMPARATOR
Intervention: BI 764524 (maximum tolerated dose) in the MD part
Number of subjects: 30
Study 33451268 — intervention group
Group type: EXPERIMENTAL
Intervention: Office-based pedal desk intervention for 3 months
Number of subjects: 40
Study 33451268 — intervention group
Group type: COMPARATOR
Intervention: Control group maintaining habitual activity
Number of subjects: 40
Study 32134208 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard multidomain intervention
Number of subjects: 1082
Study 32134208 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant empowerment
Number of subjects: 1082
Study 32134208 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1082
Study 35759826 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral isometric handgrip (IHG)
Number of subjects: 12
Study 35759826 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test (CPT)
Number of subjects: 12
Study 35759826 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-handgrip muscle ischemia (PHGMI)
Number of subjects: 12
Study 35759826 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental arithmetic test
Number of subjects: 12
Study 35759826 — intervention group
Group type: EXPERIMENTAL
Intervention: Apnea
Number of subjects: 12
Study 34386597 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 974
Study 34386597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 974
Study 34372849 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 527
Study 34372849 — intervention group
Group type: COMPARATOR
Intervention: Control (non-diabetic patients)
Number of subjects: 527
Study 32014942 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-brain radiotherapy (WBRT) with 5 fractions of 4 Gy
Number of subjects: 76
Study 32014942 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-brain radiotherapy (WBRT) with 10 fractions of 3 Gy
Number of subjects: 76
Study 32014942 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 76
Study 35569119 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentist-administered cognitive behavioural therapy (D-CBT)
Number of subjects: 96
Study 35569119 — intervention group
Group type: EXPERIMENTAL
Intervention: Four Habits communication model plus midazolam sedation
Number of subjects: 96
Study 33441760 — intervention group
Group type: EXPERIMENTAL
Intervention: Inland participants (median UIC 188.5 μg/L)
Number of subjects: 2503
Study 33441760 — intervention group
Group type: COMPARATOR
Intervention: Coastal participants (median UIC 128.5 μg/L)
Number of subjects: 2503
Study 35015777 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV (5 × 10^10 viral particles) and MVA-BN-Filo (1 × 10^8 infectious units) administered 28 or 56 days apart
Number of subjects: 263
Study 35015777 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 263
Study 33252337 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided injection with botulinum toxin
Number of subjects: 97
Study 33252337 — intervention group
Group type: COMPARATOR
Intervention: CT-guided injection without botulinum toxin (Control)
Number of subjects: 97
Study 32028804 — intervention group
Group type: EXPERIMENTAL
Intervention: Perispinal etanercept
Number of subjects: 0
Study 32028804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35138714 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin in combination with psychotherapy
Number of subjects: 0
Study 35138714 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram in combination with psychotherapy
Number of subjects: 0
Study 33676015 — intervention group
Group type: EXPERIMENTAL
Intervention: Meniscal pathology present at baseline
Number of subjects: 121
Study 33676015 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly developed meniscal pathology
Number of subjects: 121
Study 36007434 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance impaired-driving personalized feedback plus MI-style interactive text messaging intervention (PF + MIT)
Number of subjects: 97
Study 36007434 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance impaired-driving personalized feedback only intervention (PF)
Number of subjects: 97
Study 36007434 — intervention group
Group type: COMPARATOR
Intervention: Substance information control condition (IC)
Number of subjects: 97
Study 34716085 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegvaliase (Palynziq®)
Number of subjects: 0
Study 35483093 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive COVID-19 Treatment Trial
Number of subjects: 0
Study 35483093 — intervention group
Group type: EXPERIMENTAL
Intervention: Operational lessons learned from the trial
Number of subjects: 0
Study 32069516 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment A (fasting condition)
Number of subjects: 15
Study 32069516 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment B (high-calorie, high-fat meal 1 hour postdose)
Number of subjects: 15
Study 32069516 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment C (high-calorie, high-fat meal 2 hours postdose)
Number of subjects: 15
Study 36228485 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/day pyridoxine
Number of subjects: 53
Study 36228485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 33183307 — intervention group
Group type: EXPERIMENTAL
Intervention: Kypho-IORT (combined kyphoplasty and intraoperative radiotherapy)
Number of subjects: 104
Study 33296464 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2) - total daily dose of 109 CFU for 12 weeks
Number of subjects: 898
Study 33296464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 898
Study 33028383 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided needling combined with platelet-rich plasma (PRP)
Number of subjects: 58
Study 33028383 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided needling combined with saline (control group)
Number of subjects: 58
Study 33028383 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided needling combined with PRP
Number of subjects: 58
Study 36206592 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program
Number of subjects: 109
Study 36206592 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 109
Study 33349469 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote exercise instruction (exercises at home, two times a day for four weeks, followed by telephone calls)
Number of subjects: 56
Study 33349469 — intervention group
Group type: COMPARATOR
Intervention: In-person exercise instruction (exercises at the clinic, three times a week for four weeks)
Number of subjects: 56
Study 32606658 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐M14C (Eudragit®-S100 coated PLGA nanoparticles)
Number of subjects: 0
Study 32606658 — intervention group
Group type: COMPARATOR
Intervention: Commercial etoricoxib tablets
Number of subjects: 0
Study 34302312 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium prevention care protocol (n=41)
Number of subjects: 84
Study 34302312 — intervention group
Group type: COMPARATOR
Intervention: Standard nursing care (n=43)
Number of subjects: 84
Study 33280934 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality sessions for 15 min twice a week for 6 weeks
Number of subjects: 60
Study 33280934 — intervention group
Group type: COMPARATOR
Intervention: No sessions
Number of subjects: 60
Study 34196453 — intervention group
Group type: EXPERIMENTAL
Intervention: plasmaMAC
Number of subjects: 40
Study 34196453 — intervention group
Group type: EXPERIMENTAL
Intervention: UTM
Number of subjects: 40
Study 34196453 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma UTM
Number of subjects: 40
Study 34196453 — intervention group
Group type: EXPERIMENTAL
Intervention: MAC
Number of subjects: 40
Study 34196453 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated surfaces)
Number of subjects: 40
Study 32505378 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine [1.0 μg.kg‐1 body weight] and morphine [0.48 mg.kg‐1 body weight] (COM Group)
Number of subjects: 118
Study 32505378 — intervention group
Group type: COMPARATOR
Intervention: Morphine [0.48 mg.kg‐1] (MOR Group)
Number of subjects: 118
Study 32505378 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and morphine (COM Group)
Number of subjects: 118
Study 32505378 — intervention group
Group type: COMPARATOR
Intervention: Morphine (MOR Group)
Number of subjects: 118
Study 35385395 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth intervention with remote support from a lifestyle coach
Number of subjects: 2724
Study 35385395 — intervention group
Group type: EXPERIMENTAL
Intervention: High engagement group
Number of subjects: 2724
Study 35385395 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate engagement group
Number of subjects: 2724
Study 35385395 — intervention group
Group type: EXPERIMENTAL
Intervention: Low engagement group
Number of subjects: 2724
Study 35385395 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants not using a computer regularly
Number of subjects: 2724
Study 34334624 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35365139 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated PP-CSF standing orders
Number of subjects: 32
Study 35365139 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32